Daily FNArena News - Treasure Chest

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Consensus projections imply a2 Milk will grow its infant formula business at a stellar rate, but is this the case?

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Is TechnologyOne on the cusp of delivering a substantial uplift in profit? Bell Potter believes so.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. The core business of Carsales.com is solid, the long-term opportunity significant, and brokers believe the discount in the share price is unwarranted.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Several brokers point out there is more to Treasury Wine than just China and the recent sell-off may be overdone.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. A broker upgrade highlights a growing belief investor sentiment is holding back Link Administration when upside potential should suggest otherwise.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Citi upgrades QBE Insurance to Buy amidst much discussion of restructuring and the need to address reinsurance in January.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Perceived headwinds have led the market to downgrade Ramsay Health Care to five-year low multiples. Wilsons believes this is too low.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Buying Newcrest may be a better option for a large-cap gold producer, rather than trying to discover and define gold resources, Citi suggests.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. What most assumed would be a housing market cooling could now become a more disorderly affair, UBS warns.

FNArena’s Treasure Chest reports on money making ideas from stockbrokers and other experts. Morgan Stanley tackles the outlook for AMP, suggesting it may be time to review purchasing the stock.